Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Overland Park, Kansas


Purpose:

Study in healthy males to assess bioavailability of 4 different fostamatinib tablets


Criteria:

Inclusion Criteria: - Weight of at least 50 kg and body mass index (BMI) between 18.0 and 35.0 kg/m2 inclusive - Volunteers must be willing to use barrier contraception ie, condoms, from the Day 1 of Treatment Period 1 until 2 weeks after the final dosing of the investigational product (IP) Exclusion Criteria: - History of any clinically significant disease or disorder - History or presence of GI, hepatic, or renal disease or any other condition known to interfere with absorption, distribution, metabolism, or excretion of drugs (except for cholecystectomy) - Any clinically significant illness, medical/surgical procedure or trauma within 4 weeks of the first administration of drug - Volunteers who smoke more than 5 cigarettes or the equivalent in tobacco per day - Any clinically significant abnormalities in clinical chemistry, hematology or urinalysis results as judged by the Investigator


NCT ID:

NCT01208155


Primary Contact:

Study Director
Mark Layton, MD
AstraZeneca


Backup Contact:

N/A


Location Contact:

Overland Park, Kansas
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.